// App-Quantinova.ai

POS0213 (2022) : EFFECT OF EARLY ETANERCEPT TREATMENT ON CIRCULATING LIPOPROTEINS DIFFERS TO TREATMENT WITH METHOTREXATE AND IS MODULATED BY CLINICAL DISEASE ACTIVITY

Researchers

Presenter

  • R. Shukla

Principal Investigators

  • A. Burska

  • P. Emery

  • D. Plant

  • M. H. Buch

Medical Centers

  • Univ of Manchester, Centre for Musculoskeletal Research, Manchester, United Kingdom

  • Manchester University NHS Foundation Trust, NIHR Manchester Musculoskeletal Biomedical Research Unit, Manchester, United Kingdom

  • University of Leeds, Leeds Institue of Rheumatic and Musculoskeletal Medicine, Leeds, United Kingdom

  • Leeds Teaching Hospitals NHS Trust and NIHR Musculoskeletal Biomedical Research Unit, Leeds, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • TNF Receptor Superfamily Member 1B

Drug/Treatment

  • Methotrexate

  • Etanercept

  • CHS-0214

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved